I'm not arguing Kohler needed to go. His behaviour is and has been appalling IMO. I'm a former holder, not that it should be pre-requisite to following a stock.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025